Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

07/13/04 Operating on brain gets safer        

07/13/04 Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin.        

07/12/04 Abbott Labs Intends to Submit New Drug Application for Xinlay™ (Atrasentan) for men with metastatic, hormone–refractory prostate cancer [Editor's Note: mentions brain tumors also]        

07/12/04 Correction: New Medicare Drug Program Does NOT include Temodar!        

07/10/04 Adding Temozolomide (Temodar®) to Radiation Increases Survival in Glioblastoma Multiforme        

07/08/04 Peregrine Pharmaceuticals Licenses Additional Intellectual Property for Its Anti-Phospholipid Therapy Platform Technology        

07/08/04 Aspirin outdoes celecoxib in cancer avoidance model        

07/08/04 Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies.        

07/08/04 Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging.        

07/08/04 CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.        

07/08/04 Pharmacyclics Announces Initiation of Xcytrin Phase 2 Clinical Trial in Renal Cell Carcinoma        

07/08/04 TransMID drug adheres to cells in brain tumors        

07/08/04 Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations.        

07/08/04 Choroid plexus papillomas: a single institutional experience.        

07/08/04 Desferoxamine (DFO)--mediated iron chelation: rationale for a novel approach to therapy for brain cancer.        

07/08/04 Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide.        

07/08/04 Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma        

07/05/04 Intravenous, non-viral RNAi gene therapy of brain cancer        

07/04/04 Medicare to Extend Access to Certain Drugs for Beneficiaries with Serious and Chronic Illnesses [Editor's Note: includes Temodar!]        

---

Displaying Stories 5250 to 5269 of 7812
Previous 20           Next 20